FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks 
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase 
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
CUPERTINO, CA, April 12, 2018 -- Aemetis, Inc. (NASDAQ: AMTX) today announced that Universal Biofuels, the company’s India subsidiary, is producing glycerin at above nameplate capacity and demand for the product exceeds supply. The production capacity of the refined glycerin unit at the Kakinada plant is approximately 18,000 metric tonnes per year. The sale of glycerin is an important part of the company’s business strategy in India.
“Our glycerin refining facility in India is operating above nameplate capacity by importing crude glycerin from Argentina and other biodiesel production countries,” stated Eric McAfee, Chairman and CEO of Aemetis. “As our plant scales up biodiesel production using the new pre-treatment unit, the refined glycerin production unit has grown to be an important source of consistent revenues and contribution margins supplying the production of consumer and paint products in India.”
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 [email protected] Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 [email protected]
